RHÖN-KLINIKUM Aktiengesellschaft (LON:0NQH)
12.85
-0.05 (-0.39%)
At close: May 28, 2025
LON:0NQH Revenue
RHÖN-KLINIKUM Aktiengesellschaft had revenue of 479.90M EUR in the quarter ending March 31, 2025, with 5.29% growth. This brings the company's revenue in the last twelve months to 1.89B, up 7.05% year-over-year. In the year 2024, RHÖN-KLINIKUM Aktiengesellschaft had annual revenue of 1.87B with 7.67% growth.
Revenue (ttm)
1.89B EUR
Revenue Growth
+7.05%
P/S Ratio
0.46
Revenue / Employee
134.50K EUR
Employees
14,067
Market Cap
732.73M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.87B | 133.13M | 7.67% |
Dec 31, 2023 | 1.73B | 73.57M | 4.43% |
Dec 31, 2022 | 1.66B | 69.95M | 4.40% |
Dec 31, 2021 | 1.59B | 45.15M | 2.92% |
Dec 31, 2020 | 1.55B | 65.12M | 4.40% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |